Biology Reference
In-Depth Information
Acknowledgments. The studies reported in this review could not have been
performed without the precious collaboration of Drs. Roland Tubiana, Ait
Hocine Mohand, Marc-Antoine Valantin, Claudine Duvivier, and Pr. Christine
Katlama in the Service des Maladies Infectieuses, of Drs. Vincent Calvez, Con-
stance Delaugerre, and Pr. Henri Agut in Laboratoire de Virologie at HÃ pital
PitiÂ-SalpÂtriÁre; Dominique Mathez and Jacques Leibowitch in the Laboratoire
d'Immuno-virologie, HÃ pital Raymond PoincarÂ, Garches; Guy Gorochov,
BÂhazine CombadiÁre, Catherine Blanc, Nadia Alatrakchi, Fernanda Grassi,
Bernard Piqueras, Pierre Grenot, Evelyne Lefranc, and Isabelle Porcher in the
Laboratoire d'Immunologie Cellulaire, CNRS UMR 7627, directed by Pr.
Patrice Debr at Hà pital PitiÂ-SalpÂtriÁre.
REFERENCES
Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A. 2000. Maximum suppression of
HIV replication leads to the restoration of HIV-speci®c responses in early HIV disease. AIDS
14: 761±770.
Andersson J, Fehniger TE, Patterson BK, Pottage J, Agnoli M, Jones P, Behbahani H, Landay A.
1998. Early reduction of immune activation in lymphoid tissue following highly active HIV
therapy. AIDS 12: F123±F129.
Autran B, Legac E, Blanc C, Debr P. 1995. TH0/TH2 function of CD4
CD7
ÿ
T lymphocyte
subset in normal and HIV-seropositive individuals. J Immunol 154: 1408±1417.
Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J.
1997. Positive e¨ects of combined anti-retroviral therapy on CD4
T cell homeostasis and
function in advanced HIV disease. Science 277: 112±116.
Autran B, Carcelain G. 2000. Boosting immunity to HIVÐcan the virus help? Science 290: 946±949.
Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E,
Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. 1998. In vivo analysis of Fas/Fas-L
interactions in HIV-infected patients. J Clin Invest 102: 79±87.
Bell ES, Sparshott SM. 1990. Interconversion of CD45R of CD4 T cells in vivo. Nature 348: 163±
166.
Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, Kaneshima H. 1993. HIV
induces thymus depletion in vivo. Nature 363: 728±732.
Borthwick NJ, Bo®ll M, Gombert WM, Akbar AN, Medina E, Sagawa K, Lipman MC, Johnson
MA, Janossy G. 1994. Lymphocyte activation in HIV-1 infection II. Functional defects of
CD28 T cells. AIDS 8: 431±441.
Buchbinder SP, Holmberg SD, Scheer S, Colfax G, O'Malley P, Vittingho¨ E. 1999. Combination
antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune De®c
Syndr 21 (Suppl 1): S23±S26.
Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, Mitsuyasu RT, Kilby JM.
1999. Initial increase in blood CD4() lymphocytes after HIV retroviral therapy re¯ects redis-
tribution from lymphoid tissues. J Clin Invest 103: 1391±1398.
Calarota SA, Leandersson AC, Bratt G, Hinkula J, Klinman DM, Weinhold KJ, Sandstrom E,
Wahren B. 1999. Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA
immunization followed by highly active antiretroviral treatment. J Immunol 163: 2330±2338.
Carcelain G, Blanc C, Leibowitch J, Mariot P, Mathez D, Schneider V, Saimot AG, Damont F,
Simon F, Debre P, Autran B, Girard PM. 1999. T-cell changes after combined nucleoside ana-
logue therapy in HIV primary infection. AIDS 13: 1077±1081.
